Skip to content

Shahar Almog

3 papers in the library · 1 citation · publishing 2025

Papers

Sort Most recent Most cited

Self-Reported Improvements in Comorbid Post-Traumatic Stress Disorder Symptoms, Depression, Anxiety, and Sleep Among Real-World Patients Receiving Medical Ketamine: Exploring the Role of Adjunct Therapies.

European journal of trauma & dissociation = Revue europeenne du trauma et de la dissociation September 1, 2025 Shahar Almog, Albert Garcia‐romeu, Kathryn Walker et al. 1 citation

Post-traumatic stress disorder (PTSD) presents severe symptomology and often co-occurs with depression, warranting novel treatment approaches to address both conditions simultaneously. Ketamine has emerged as a rapid antidepressant and potential treatment for PTSD, with some real-world evidence for effectiveness regardless of comorbidities. The purpose of this secondary analysis was to explore...

Self-reported changes and experiences with substance use among real-world patients treated with medical ketamine.

Experimental and Clinical Psychopharmacology July 24, 2025 Shahar Almog, Maribel Rodriguez Perez, Deepthi S Varma et al.

Ketamine is increasingly used in community clinics as a long-term treatment for different psychiatric and pain conditions, including substance use disorders. Data are lacking, however, regarding the potential influence of ketamine on other substance use. In this secondary analysis, we aimed to explore the relationship between medical ketamine and other substance use among real-world patients by...

Treating chronic pain with low dose ketamine and adjunct therapies within a biopsychosocial approach: a case series.

Frontiers in pain research (Lausanne, Switzerland) 2025 Shahar Almog, Michelle Weiner, Jessica N Howarth et al.

Chronic pain is an individual experience with physical and psychological dimensions. Ketamine is used in sub-anesthetic doses to treat chronic pain. We describe a proposed multidisciplinary approach with combined treatment of low-dose ketamine and pain-focused psychological and somatic therapies to benefit quality of life of disabled chronic pain patients. Beyond pain reduction, within the...